{"id":2776,"date":"2022-05-26T14:20:12","date_gmt":"2022-05-26T13:20:12","guid":{"rendered":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png"},"modified":"2022-05-26T14:20:12","modified_gmt":"2022-05-26T13:20:12","slug":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-2","status":"inherit","type":"attachment","link":"https:\/\/bibliography.nanobiotix.com\/fr\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-2\/","title":{"rendered":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial"},"author":1,"comment_status":"open","ping_status":"closed","template":"","meta":[],"aioseo_notices":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png'><img width=\"232\" height=\"300\" src=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-232x300.png\" class=\"attachment-medium size-medium\" alt=\"\" decoding=\"async\" loading=\"lazy\" srcset=\"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-232x300.png 232w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-793x1024.png 793w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-768x992.png 768w, https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png 800w\" sizes=\"(max-width: 232px) 100vw, 232px\" \/><\/a><\/p>\n"},"caption":{"rendered":""},"alt_text":"","media_type":"image","mime_type":"image\/png","media_details":{"width":800,"height":1033,"file":"2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png","sizes":{"medium":{"file":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-232x300.png","width":232,"height":300,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-232x300.png"},"large":{"file":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-793x1024.png","width":793,"height":1024,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-793x1024.png"},"thumbnail":{"file":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-150x150.png","width":150,"height":150,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-150x150.png"},"medium_large":{"file":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-768x992.png","width":768,"height":992,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial-768x992.png"},"full":{"file":"2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png","width":800,"height":1033,"mime_type":"image\/png","source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png"}},"image_meta":{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0","keywords":[]}},"post":2734,"source_url":"https:\/\/bibliography.nanobiotix.com\/wp-content\/uploads\/2022\/05\/2020-nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in-cisplatin-ineligible-patients-with-locally-advanced-hnscc-a-phase-i-trial.png","_links":{"self":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media\/2776"}],"collection":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bibliography.nanobiotix.com\/fr\/wp-json\/wp\/v2\/comments?post=2776"}]}}